Receptor News and Research

RSS

Astrocyte-targeted treatment may help alleviate symptoms of Alzheimer’s disease

A study by scientists of the German Center for Neurodegenerative Diseases points to a novel potential approach against Alzheimer's disease.

4 May 2018

Sylentis presents clinical study results of new treatment for dry eye syndrome

Sylentis, Pharmaceutical Company belonging to the PharmaMar Group, has presented results from the clinical studies carried out with tivanisiran for the treatment of dry eye syndrome and that has enabled the start-up of the Phase III "Helix" clinical trial.

3 May 2018

3D structures of nicotine receptor could lead to new ways for treating addiction

UT Southwestern researchers today published in Nature atomic-scale blueprints of the most abundant class of brain nicotinic acetylcholine receptors. A structural understanding of the protein, found in neurons, could lead to new ways to treat nicotine addiction from smoking and vaping.

3 May 2018

UTA investigators examine link between ovarian hormones and blood cholesterol balance

Researchers at The University of Texas at Arlington are investigating the link between ovarian hormones and the blood cholesterol balance in the body, itself a key determinant of cardiovascular health or disease.

3 May 2018

Research team uncovers link between circadian clock and aggression center in the brain

Each year around many people worldwide are diagnosed with a form of dementia. Alzheimer's disease is one of them. The disease manifests itself in memory difficulties in particular, but can also result in personality changes and mood swings.

2 May 2018

Researchers develop novel theranostic procedure for treating ductal pancreatic adenocarcinoma

German researchers have developed a novel diagnostic and therapeutic (theranostic) procedure for patients with ductal pancreatic adenocarcinoma, a deadly cancer with an extremely poor prognosis (five-year survival rate of less than 5 percent) and limited treatment options. The study is featured in the May issue of The Journal of Nuclear Medicine.

2 May 2018

Researchers find novel approach for in vivo real-time monitoring of metabolites

Real-time monitoring of the dynamics of endogenous molecules in organisms is an important aspect in the study of diseases.

2 May 2018

Breast cancer drug can accelerate growth of tumors, shows research

The breast cancer drug lapatinib which is designed to shrink tumours can sometimes cause them to grow in the lab, according to a new study published in eLife.

2 May 2018

New vaccine strategy increases number of tumor-specific cancer-killing T cells

New research published in Cancer Immunology Research by Drs. Esteban Celis and Hussein Sultan of the Georgia Cancer Center at Augusta University could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking tumors in the human body.

2 May 2018

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia don't respond to chimeric antigen receptor T cell therapy, and the answer is tied to how primed patients' immune systems are before the therapy is administered.

30 Apr 2018

New studies could offer novel treatments for vision and eye conditions

Three new studies demonstrate research findings that could offer novel treatments for vision and eye conditions.

30 Apr 2018

University of Pennsylvania expert investigates novel treatment for cocaine addiction

Cocaine and other drugs of abuse hijack the natural reward circuits in the brain. In part, that's why it's so hard to quit using these substances.

28 Apr 2018

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it has launched Proniras Corporation, a company developing tezampanel for the treatment of a variety of seizure disorders.

27 Apr 2018

Researchers recommend anti-cancer immunotherapies for treatment of thyroid cancer

University of Colorado Cancer Center researchers recently completed the largest-ever study of thyroid cancer genetics, mining the data of 583 patient samples of advanced differentiated thyroid cancer and 196 anaplastic thyroid cancers.

27 Apr 2018

New CAR-T therapy could provide safer, more effective cancer treatment

There have been few cancer treatments with such a promising future as using the patient's own immune system.

27 Apr 2018

Research leads to new potential treatment for Hereditary Hemorrhagic Telangiectasia

The work of researchers Francesc Viñals and Mariona Graupera at the Bellvitge Biomedical Research Institute - Catalan Institute of Oncology - University of Barcelona, together with Dr. Antoni Riera-Mestre, has led to a new potential treatment for Hereditary Hemorrhagic Telangiectasia or Rendu-Osler Syndrome, a rare disease that affects blood vessels and had no described treatment.

26 Apr 2018

Receptor News and Research

Astrocyte-targeted treatment may help alleviate symptoms of Alzheimer’s disease

Sylentis presents clinical study results of new treatment for dry eye syndrome

3D structures of nicotine receptor could lead to new ways for treating addiction

UTA investigators examine link between ovarian hormones and blood cholesterol balance

Research team uncovers link between circadian clock and aggression center in the brain

Researchers develop novel theranostic procedure for treating ductal pancreatic adenocarcinoma

Researchers find novel approach for in vivo real-time monitoring of metabolites

Breast cancer drug can accelerate growth of tumors, shows research

New vaccine strategy increases number of tumor-specific cancer-killing T cells

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

New studies could offer novel treatments for vision and eye conditions

University of Pennsylvania expert investigates novel treatment for cocaine addiction

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

Researchers recommend anti-cancer immunotherapies for treatment of thyroid cancer

New CAR-T therapy could provide safer, more effective cancer treatment

Research leads to new potential treatment for Hereditary Hemorrhagic Telangiectasia

Exploiting rabies virus machinery to usher Parkinson's disease drug directly to the brain

Scientists discover culprit in reducing effectiveness of insulin

Bariatric surgery successes pave way for new type 2 diabetes treatment

New compound could offer pain-relieving properties without risk of addiction

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News